Vimarsana
Biggest News Aggregation in the World

Page 20 - Human Use News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Human Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Human Use Today - Breaking & Trending Today

Drug for Overactive Bladder Recommended in Europe - Vimarsana News

Drug for Overactive Bladder Recommended in Europe

Obgemsa is suitable for treating symptoms of an overactive bladder in adults, the European Medicines Agency has determined.

New Contraindications to Coadministration of Atazanavir - Vimarsana News

New Contraindications to Coadministration of Atazanavir

New restrictions have been imposed by the European Medicines Agency on the coadministration of the anti-HIV drug atazanavir with a variety of other agents.

Two Biosimilars Approved in Europe for Autoimmune Disorders - Vimarsana News

Two Biosimilars Approved in Europe for Autoimmune Disorders

The drugs are intended to treat several types of arthritis, psoriasis, COVID-19, and Crohn's disease.

PTC Therapeutics : Q1 2024 FLS - MarketScreener - Vimarsana News

PTC Therapeutics : Q1 2024 FLS - MarketScreener

Forward-Looking Statements This call will have forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. All...

Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting - Vimarsana News

Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting

/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the European Commission (EC) has approved a...